AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $18,999,000 | +49.2% | 2,021,177 | +21.4% | 0.01% | +25.0% |
| Q2 2020 | $12,737,000 | +8.6% | 1,664,957 | -12.3% | 0.00% | 0.0% |
| Q1 2020 | $11,732,000 | -53.8% | 1,898,431 | -9.1% | 0.00% | -33.3% |
| Q4 2019 | $25,413,000 | +106.7% | 2,088,090 | +96.1% | 0.01% | +100.0% |
| Q3 2019 | $12,295,000 | +586.5% | 1,064,581 | +494.0% | 0.00% | – |
| Q2 2019 | $1,791,000 | -27.8% | 179,236 | -7.0% | 0.00% | -100.0% |
| Q1 2019 | $2,482,000 | -29.3% | 192,651 | -16.7% | 0.00% | 0.0% |
| Q4 2018 | $3,512,000 | -3.9% | 231,224 | +26.6% | 0.00% | 0.0% |
| Q3 2018 | $3,654,000 | +23.5% | 182,698 | +20.4% | 0.00% | 0.0% |
| Q2 2018 | $2,959,000 | -13.1% | 151,727 | -10.2% | 0.00% | 0.0% |
| Q1 2018 | $3,406,000 | +11.0% | 169,027 | -27.0% | 0.00% | 0.0% |
| Q4 2017 | $3,069,000 | -73.7% | 231,655 | -63.3% | 0.00% | -66.7% |
| Q3 2017 | $11,651,000 | +13.2% | 631,471 | +12.8% | 0.00% | 0.0% |
| Q2 2017 | $10,296,000 | -24.9% | 559,590 | -8.0% | 0.00% | -25.0% |
| Q1 2017 | $13,710,000 | +69.9% | 607,980 | +162.2% | 0.00% | +100.0% |
| Q4 2016 | $8,068,000 | +405.5% | 231,841 | +256.1% | 0.00% | – |
| Q3 2016 | $1,596,000 | -34.3% | 65,113 | -35.9% | 0.00% | -100.0% |
| Q2 2016 | $2,430,000 | -62.6% | 101,563 | -63.5% | 0.00% | -50.0% |
| Q1 2016 | $6,506,000 | +22.4% | 278,051 | +58.0% | 0.00% | 0.0% |
| Q4 2015 | $5,314,000 | -5.4% | 175,990 | +24.5% | 0.00% | 0.0% |
| Q3 2015 | $5,617,000 | -55.3% | 141,380 | -22.3% | 0.00% | -50.0% |
| Q2 2015 | $12,559,000 | +239.9% | 181,852 | +169.0% | 0.00% | +300.0% |
| Q1 2015 | $3,695,000 | +36.3% | 67,604 | +6.3% | 0.00% | 0.0% |
| Q4 2014 | $2,711,000 | -51.6% | 63,606 | -63.8% | 0.00% | 0.0% |
| Q3 2014 | $5,607,000 | +81.3% | 175,723 | +17.7% | 0.00% | – |
| Q2 2014 | $3,093,000 | -36.6% | 149,275 | -40.8% | 0.00% | -100.0% |
| Q1 2014 | $4,878,000 | +15.5% | 252,125 | +44.9% | 0.00% | 0.0% |
| Q4 2013 | $4,225,000 | +151.8% | 174,031 | +122.7% | 0.00% | 0.0% |
| Q3 2013 | $1,678,000 | +17.3% | 78,151 | +21.6% | 0.00% | 0.0% |
| Q2 2013 | $1,430,000 | -12.4% | 64,292 | -42.1% | 0.00% | 0.0% |
| Q4 2012 | $1,632,000 | +2.3% | 110,972 | +23.4% | 0.00% | 0.0% |
| Q3 2012 | $1,596,000 | +30.1% | 89,930 | +12.9% | 0.00% | 0.0% |
| Q2 2012 | $1,227,000 | -38.4% | 79,680 | -36.3% | 0.00% | 0.0% |
| Q1 2012 | $1,993,000 | – | 125,074 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |